XP-Tech Team

 

Dr. Peter Xaysanasy

President & CEO XP Technology, Founder and Chief Technology Officer  ELG3 Corporation & Pharmico International Corporation

  • Northwest Arkansas Podiatry Center, Fayetteville AR CEO/Physician (2000-2012)

  • Northwest Medical Center, Springdale AR Staff Physician Department of Surgery (2004-2010)

  • Mercy Hospital, Waldron, AR Staff Physician Department of Podiatric Medicine and Surgery (2001-2012)

  • Booneville Community Hospital, Booneville, AR Staff Physician Dept. of Surgery (2001-2012)

  • University of Arkansas, Fayetteville AR consultant physician to Track and Field, Lady Razorbacks basketball (2004-2007)

  • Oganogenesis Pharmaceutical, consultant/lecturers on diabetic skin grafts clinical trials (Medicare and Medicaid study base provisions) 2002-2005

  • Tyson Foods, Inc. Springdale AR Chemist R&D, Analytical and Spectroscopy, developed vitamin C-isomers extraction (1990-1994)

  • Northwest Medical Center, Springdale AR, Medical Technologist, Chemistry and Hematology (1990-1991)

 Dr. Joe P. Rouse M.D.

Clinical Trial Principal Investigator-Springdale, AR

  • Board Certified physician in Family Medicine by the American Board of Family Medicine

  • Specialist in emergency and family medicine

  • 52 years experience

  • Graduated with honors from the University of Arkansas For Medical Sciences College of Medicine

  • United States Naval Medical Center Residency

John Fahner-Vihtelic

Sr. Licensing Mgr. University of Rochester Medical Center

  • IP Professional 23 yrs.

  • 9 years with NIH device and instrument portfolio.

  • Licensing mgr. University of Rochester Medical Center

Tonya R. Xaysanasy

MA; Co-founder, managing director of ELG-3 FDA clinical trial and Partner at Pharmico International

• Co-founder XP Tech. & ELG-3

• Managing Director of ELG-3 FDA clinical trial and Managing Partner Pharmico International Corporation

• Coordination & implementation of IRB/FDA protocols, subjects pre-screening, safety, & Labcorp sample procedures

Dr. Raymond Rackley

Consultant, Cleveland, OH

  • Professor at the Cleveland Clinic Lerner College of Medicine

  • Professor of the Center for Pelvic Medicine and Reconstructive Surgery at the world’s premier Glickman Urological & Kidney Institute of the Cleveland Clinic

  • Serves as national and international clinical consultant and Speaker with over 1,400 peer-reviewed medical and scholarship citations listed in google Scholar/PubMed.

  • He has an extensive history with FDA clinical trial studies, drug delivery systems and manufacturing

  • He is currently serving as the consulting Chief Medical Office for ARMS Pharmaceutical’s FDA IND #119621 for Influenza Prevention & Symptom Reduction Treatment

  • Recently granted FDA IND 149319 for COVID Prevention & Symptom Reduction Treatment

David Rosen LLP

Attorney at Law, Washington, D.C.

  • Partner with Foley and Lardner LLP.

  • Specializes in FDA regulatory issues

  • Co-Chair of Life Science Industry team

  • 14 years with the FDA

  • AV® Preeminent Peer Review Rated

Lee Chen

VP and Managing Partner ELG-3 and Pharmico International Corporation, Rochester, NY

  • Managing Partner and Vice President of ELG 3 and Pharmico International.

  • VP & GM of specialty chemical manufacturing company providing disinfectants, hygiene solutions and water treatment technologies

  • Partner- Importex Inc. Import/export of commodities

Pace Electronics

Engineering and Design, Sodus, NY

  • U.S. and China based electronic development and manufacturer

  • Engineering and Design

  • ISO certified

  • Walmart approved manufacturer